Q1 2025 Management View CEO Chris Anzalone announced the closure of a significant licensing and collaboration agreement with Sarepta Therapeutics, which will provide $1.375 billion in upfront and near ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting a conference call today, February 10, ...

CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL: San Diego Friday, February 7, 2025, 15:00 Hr ...

Arrowhead Pharmaceuticals, Inc. ( NASDAQ: ARWR) Q1 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Chris Anzalone - President & CEO Bruce Given - Interim Chief Medical Scientist Andy Davis ...

Drinking alcohol — even in moderate amounts — can increase your triglyceride levels. And high triglyceride levels can raise your risk of certain health conditions, including stroke, heart ...

Shen et al. report a method for multiplexing isogenic iPSCs for single-cell RNA-seq. With it, they created an atlas of in vitro differentiation and identified TMEM88 as a regulator of ...

Severe hypertriglyceridemia (≥500 mg/dl [5.65 mmol/l]) should be treated to reduce the risk of pancreatitis. The omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA ...

Simultaneous profiling of the genome, methylome, epigenome and transcriptome using single-molecule chromatin fiber sequencing and multiplexed arrays isoform sequencing identifies the genetic and ...

After hours: February 7 at 6:00:15 PM EST Loading Chart for IONS ...